Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $57.28 in the prior trading day, Hologic, Inc (NASDAQ: HOLX) closed at $54.16, down -5.45%. In other words, the price has decreased by -$5.45 from its previous closing price. On the day, 7.84 million shares were traded. HOLX stock price reached its highest trading level at $55.5275 during the session, while it also had its lowest trading level at $52.12.
Ratios:
Our goal is to gain a better understanding of HOLX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.21. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.53.
On February 06, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $80 to $75.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when Mitchell Essex D sold 24,856 shares for $76.34 per share. The transaction valued at 1,897,482 led to the insider holds 27,957 shares of the business.
Mitchell Essex D bought 24,856 shares of HOLX for $1,897,484 on Dec 04 ’24. On Aug 29 ’24, another insider, Oberton Karleen Marie, who serves as the Chief Financial Officer of the company, sold 52,679 shares for $80.56 each. As a result, the insider received 4,243,662 and left with 84,042 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOLX now has a Market Capitalization of 12069284864 and an Enterprise Value of 12974598144. As of this moment, Hologic,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.87, and their Forward P/E ratio for the next fiscal year is 11.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.02 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 3.222 whereas that against EBITDA is 10.361.
Stock Price History:
The Beta on a monthly basis for HOLX is 0.53, which has changed by -0.28671145 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, HOLX has reached a high of $84.67, while it has fallen to a 52-week low of $55.89. The 50-Day Moving Average of the stock is -10.73%, while the 200-Day Moving Average is calculated to be -25.85%.
Shares Statistics:
The stock has traded on average 2.90M shares per day over the past 3-months and 2673920 shares per day over the last 10 days, according to various share statistics. A total of 224.39M shares are outstanding, with a floating share count of 222.47M. Insiders hold about 0.86% of the company’s shares, while institutions hold 103.53% stake in the company. Shares short for HOLX as of 1744675200 were 6711477 with a Short Ratio of 2.31, compared to 1741910400 on 5867536. Therefore, it implies a Short% of Shares Outstanding of 6711477 and a Short% of Float of 3.9699999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
